Obsidian Therapeutics Q3 EPS $(1.23) Up From $(14.77) YoY
Benzinga Newsdesk 1 day ago
NewsEarnings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Obsidian Therapeutics (NASDAQ:OBX) reported quarterly losses of $(1.23) per share. This is a 91.67 percent increase over losses of $(14.77) per share from the same period last year.
Obsidian Therapeutics (NASDAQ:OBX) reported quarterly losses of $(1.23) per share. This is a 91.67 percent increase over losses of $(14.77) per share from the same period last year.